| Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China Y Lin, Z Hu, Q Zhao, H Alias, M Danaee, LP Wong PLoS neglected tropical diseases 14 (12), e0008961, 2020 | 757 | 2020 |
| Virus-like particle-based human vaccines: quality assessment based on structural and functional properties Q Zhao, S Li, H Yu, N Xia, Y Modis Trends in biotechnology 31 (11), 654-663, 2013 | 241 | 2013 |
| NMR evidence for the participation of a low-barrier hydrogen bond in the mechanism of delta 5-3-ketosteroid isomerase. Q Zhao, C Abeygunawardana, P Talalay, AS Mildvan Proceedings of the National Academy of Sciences 93 (16), 8220-8224, 1996 | 164 | 1996 |
| Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD (P) H: quinone reductase (DT-diaphorase) Q Zhao, XL Yang, WD Holtzclaw, P Talalay Proceedings of the National Academy of Sciences 94 (5), 1669-1674, 1997 | 155 | 1997 |
| Complexities in horseradish peroxidase-catalyzed oxidation of dihydroxyphenoxazine derivatives: appropriate ranges for pH values and hydrogen peroxide concentrations in … V Towne, M Will, B Oswald, Q Zhao Analytical biochemistry 334 (2), 290-296, 2004 | 152 | 2004 |
| Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen TY Zhang, Q Yuan, JH Zhao, YL Zhang, LZ Yuan, Y Lan, YC Lo, CP Sun, ... Gut 65 (4), 658-671, 2016 | 148 | 2016 |
| Crystal Structure of Human Quinone Reductase Type 2, a Metalloflavoprotein, CE Foster, MA Bianchet, P Talalay, Q Zhao, LM Amzel Biochemistry 38 (31), 9881-9886, 1999 | 142 | 1999 |
| Escherichia coli-derived virus-like particles in vaccine development X Huang, X Wang, J Zhang, N Xia, Q Zhao npj Vaccines 2 (1), 3, 2017 | 141 | 2017 |
| The development of a recombinant hepatitis E vaccine HEV 239 SW Li, Q Zhao, T Wu, S Chen, J Zhang, NS Xia Human vaccines & immunotherapeutics 11 (4), 908-914, 2015 | 141 | 2015 |
| Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity Q Zhao, Y Modis, K High, V Towne, Y Meng, Y Wang, J Alexandroff, ... Virology journal 9, 1-14, 2012 | 132 | 2012 |
| COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries LP Wong, H Alias, M Danaee, J Ahmed, A Lachyan, CZ Cai, Y Lin, Z Hu, ... Infectious diseases of poverty 10, 1-14, 2021 | 130 | 2021 |
| Hepatitis E vaccine development: a 14 year odyssey T Wu, SW Li, J Zhang, MH Ng, NS Xia, Q Zhao Human vaccines & immunotherapeutics 8 (6), 823-827, 2012 | 121 | 2012 |
| Hydrogen Bonding at the Active Site of Δ5-3-Ketosteroid Isomerase Q Zhao, C Abeygunawardana, AG Gittis, AS Mildvan Biochemistry 36 (48), 14616-14626, 1997 | 117 | 1997 |
| Replication, pathogenicity, and transmission of SARS-CoV-2 in minks L Shuai, G Zhong, Q Yuan, Z Wen, C Wang, X He, R Liu, J Wang, Q Zhao, ... National Science Review 8 (3), nwaa291, 2021 | 99 | 2021 |
| Global vaccine action plan lessons learned I: Recommendations for the next decade N MacDonald, E Mohsni, Y Al-Mazrou, JK Andrus, N Arora, S Elden, ... Vaccine 38 (33), 5364-5371, 2020 | 99 | 2020 |
| Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles Q Zhao, MJ Allen, Y Wang, B Wang, N Wang, L Shi, RD Sitrin Nanomedicine: Nanotechnology, Biology and Medicine 8 (7), 1182-1189, 2012 | 98 | 2012 |
| Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin® X Zhang, M Wei, H Pan, Z Lin, K Wang, Z Weng, Y Zhu, L Xin, J Zhang, ... Vaccine 32 (32), 4039-4050, 2014 | 96 | 2014 |
| Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus TM Fu, DC Freed, MS Horton, J Fan, MP Citron, JG Joyce, VM Garsky, ... Virology 385 (1), 218-226, 2009 | 96 | 2009 |
| Molecular and functional analysis of monoclonal antibodies in support of biologics development X Wang, Z An, W Luo, N Xia, Q Zhao Protein & cell 9 (1), 74-85, 2018 | 94 | 2018 |
| Calcium phosphate nanoparticles as a new generation vaccine adjuvant Y Lin, X Wang, X Huang, J Zhang, N Xia, Q Zhao Expert review of vaccines 16 (9), 895-906, 2017 | 87 | 2017 |
